ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Get Free Report)’s stock price crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $54.08 and traded as low as $52.40. ProShares Ultra Nasdaq Biotechnology shares last traded at $55.13, with a volume of 14,819 shares traded.
ProShares Ultra Nasdaq Biotechnology Stock Performance
The business’s 50 day moving average price is $54.08 and its two-hundred day moving average price is $60.75.
ProShares Ultra Nasdaq Biotechnology Increases Dividend
The company also recently announced a dividend, which was paid on Tuesday, December 31st. Shareholders of record on Monday, December 23rd were issued a dividend of $0.3964 per share. This is an increase from ProShares Ultra Nasdaq Biotechnology’s previous dividend of $0.15. The ex-dividend date was Monday, December 23rd.
Institutional Inflows and Outflows
About ProShares Ultra Nasdaq Biotechnology
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.
Featured Articles
- Five stocks we like better than ProShares Ultra Nasdaq Biotechnology
- What is Short Interest? How to Use It
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- The Basics of Support and Resistance
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- ESG Stocks, What Investors Should Know
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.